H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.53 HKD 4.79% Market Closed
Market Cap: 1.5B HKD
Have any thoughts about
Hua Medicine?
Write Note

Hua Medicine
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hua Medicine
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
H
Hua Medicine
HKEX:2552
Tax Provision
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Tax Provision
-ÂĄ488.7m
CAGR 3-Years
3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Tax Provision
-ÂĄ554.6m
CAGR 3-Years
-10%
CAGR 5-Years
-19%
CAGR 10-Years
-25%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Tax Provision
-ÂĄ498.4m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
-9%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Tax Provision
-ÂĄ637.7m
CAGR 3-Years
18%
CAGR 5-Years
-9%
CAGR 10-Years
-4%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Tax Provision
-ÂĄ11.5m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hua Medicine
Glance View

Market Cap
1.5B HKD
Industry
Pharmaceuticals

Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 146 full-time employees. The company went IPO on 2018-09-14. The firm is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The firm mainly operates its business in the domestic and overseas markets.

Intrinsic Value
0.34 HKD
Overvaluation 78%
Intrinsic Value
Price
H

See Also

What is Hua Medicine's Tax Provision?
Tax Provision
0 CNY

Based on the financial report for Jun 30, 2024, Hua Medicine's Tax Provision amounts to 0 CNY.

Back to Top